CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Oct. 30, 2022	Oct. 31, 2021
Cash flows from operating activities:
Net (loss) income	$ (17,872,000)	$ 3,101,000
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Depreciation	3,489,000	3,471,000
Non-cash inventory charges	6,439,000	579,000
Amortization	214,000	267,000
Stock-based compensation	565,000	709,000
Deferred income taxes	(269,000)	(319,000)
Realized gain from the sale of short-term investments available for sale		(4,000)
Gain sale of equipment	(232,000)
Foreign currency exchange (gain) loss	(1,168,000)	170,000
Changes in assets and liabilities:
Accounts receivable	(443,000)	5,441,000
Inventories	7,192,000	(8,329,000)
Other current assets	(728,000)	39,000
Other assets	58,000	(987,000)
Accounts payable – trade	6,027,000	(2,269,000)
Deferred revenue	1,007,000	139,000
Accrued expenses and deferred compensation	1,254,000	(2,908,000)
Accrued restructuring	33,000
Income taxes	601,000	(428,000)
Net cash provided by (used in) operating activities	6,167,000	(1,328,000)
Cash flows from investing activities:
Capital expenditures	(1,051,000)	(3,901,000)
Proceeds from the sale of equipment	465,000
Proceeds from the maturity of short-term investments (Held to Maturity)		3,200,000
Purchase of short-term and long-term investments (Held to Maturity)		(8,876,000)
Purchase of short-term investments (Available for Sale)		(4,371,000)
Proceeds from the sale of long-term investments (rabbi trust)	46,000
Proceeds from the sale of short-term investments (Available for Sale)		306,000
Purchase of long-term investments (rabbi trust)	(505,000)	(580,000)
Net cash used in investing activities	(1,045,000)	(14,222,000)
Cash flows from financing activities:
Dividends paid		(2,699,000)
Common stock repurchased		(1,752,000)
Common stock surrendered for withholding taxes payable	(33,000)	(50,000)
Payments of debt issuance costs	(206,000)
Net cash used in financing activities	(239,000)	(4,501,000)
Effect of exchange rate changes on cash and cash equivalents	(296,000)	(2,000)
Increase (decrease) in cash and cash equivalents	4,587,000	(20,053,000)
Cash and cash equivalents at beginning of period	14,550,000	37,009,000
Cash and cash equivalents at end of period	$ 19,137,000	$ 16,956,000